Pancreatic adenosquamous carcinoma

MONDO:0005614

A carcinoma that arises from the pancreas showing both ductal and squamous differentiation. The squamous component should represent at least 30% of the malignant cellular infiltrate. The prognosis is usually worse than that of ductal adenocarcinoma.

Also known as: adenosquamous carcinoma of pancreas, adenosquamous carcinoma of the pancreas, adenosquamous pancreas carcinoma, pancreas adenosquamous carcinoma, pancreatic adenoacanthoma, pancreatic adenosquamous cancer, pancreatic adenosquamous carcinoma, pancreatic mixed squamous and adenocarcinoma

2895 clinical trials for this condition and its sub-types, 13 tagged with Pancreatic adenosquamous carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Adenosquamous carcinoma (45) ↑ Squamous cell carcinoma of pancreas (13)

Including sub-types (2895) Tagged with Pancreatic adenosquamous carcinoma (13)

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1

New drug combo aims to tackle deadly pancreatic cancer

Disease control Not yet recruiting

This study tests a new drug called samuraciclib added to standard chemotherapy for people with a specific type of advanced pancreatic cancer (basal-like). The goal is to find the safest dose and see if the combination helps shrink tumors or slow the cancer. About 67 adults with n…

Phase 1/2 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

Pancreatic adenosquamous carcinoma

Where it sits in the disease tree

New drug combo aims to tackle deadly pancreatic cancer